Drug Retention of First-Line Biologic Therapies in Rheumatoid Arthritis: Real-World Evidence From a Moroccan Cohort.

Cureus · 2026 · PMC13243749 · PMID 42266298

Europe PMC DOI

hedged sentences

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

showed a trendp = 0.057so close (0.05 < p ≤ 0.1)

Concomitant conventional synthetic DMARD use showed a trend toward better retention (HR = 0.57, 95% CI: 0.32-1.02, p = 0.057), as did lower SDAI scores (HR = 0.97, 95% CI: 0.95-1.00, p = 0.057).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Golimumab and Infliximab did not reach statistical significance, likely due to their limited sample sizes (n = 1 and n = 4, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.